Logo

Amersham Licenses Protein Separation Technology from Denmark s UpFront Chromatography

Sep 03, 2002

NEW YORK, Sept. 3-Amersham Biosciences has licensed a set of protein capture-related patents from UpFront Chromatography, the company said today.


The patents cover expanded bed adsorption techniques, a streamlined method of capturing proteins from crude biological samples. Amersham plans to use UpFront's EBA technology to improve its Streamline protein separation platform.

 

As part of this agreement, UpFront Chromatography will receive non-exclusive rights to Amersham's own EBA patents.

 

UpFront Chromatography, which develops protein chemistry and chromatographic adsorption techniques, is based in Copenhagen, Denmark.

Breaking News
The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.